Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-001966

CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $22.68 ($340,197)

  • CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-01 Exercise or conversion : show line 1 in the form +15,000 $2.14 $32,100 15,000 D
2023-02-01 Sale : show line 2 in the form −10,505 $22.52 $236,586 4,495 D
2023-02-01 Sale : show line 3 in the form −4,495 $23.05 $103,611 0 D
Open-market sales · 15,000 sh · avg $22.68 · $340,197

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-02-01 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −15,000 $2.14 2031-04-01 15,000 448,381 D
Loading xslF345X03/form4-02032023_060202.xml…